Evolent Health, Inc.
EVH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $1 | $1 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 7.9% | -8.1% | -25.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 20.8% | 22.6% | 21.2% | 11.7% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 3% | 2.9% | -5.9% | 2.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.4% | -4.5% | -13.4% | -3.5% |
| EPS Diluted | -0.24 | -0.44 | -0.63 | -0.27 |
| % Growth | 45.5% | 30.2% | -133.3% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |